Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is 890,74 €, with a 24-hour trading volume of 3,43B €. The asset's market cap is 797,23B €, after moving 0.53% in the last day.
Tokenized Eli Lilly And Co is trading at 893,76 €, with a tokenized market cap of 4,91M € and a 24-hour trading volume of 1,08M €. The tokenized asset has moved -0.21% in the past 24 hours.